Press release
Myelofibrosis Clinical Trial Pipeline Accelerates as 35+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Download DelveInsight's comprehensive Myelofibrosis Pipeline Report to explore emerging therapies, key Companies, and future treatment landscapes @ https://www.delveinsight.com/sample-request/myelofibrosis-pipeline-insight [https://www.delveinsight.com/sample-request/myelofibrosis-pipeline-insight?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Myelofibrosis Pipeline Report
* On January 23, 2026- Disc Medicine Inc. initiated a phase 1b/2a open-label study will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of DISC-0974 as well as categorize the effects on anemia response in subjects with myelofibrosis or myelodysplastic syndrome and anemia.
* On January 20, 2026- AbbVie announced a Phase 2 open-label, multicenter study evaluating tolerability and efficacy of navitoclax alone or when added to ruxolitinib in participants with myelofibrosis.
* On January 16, 2026- iOnctura clinical trial is to learn how roginolisib works in comparison to standard treatment in adult patients with Myelofibrosis. The main questions it aims to answer is to evaluate the safety and tolerability of roginolisib when administered in combination with ruxolitinib.
* On January 09, 2026- Swedish Orphan Biovitrum conducted a study (study ID PAC203 North America; PAC303 ex-North America) is evaluating 200 mg BID of pacritinib compared to physician's choice (P/C) therapy in patients with MF and severe thrombocytopenia (platelet count
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Myelofibrosis Clinical Trial Pipeline Accelerates as 35+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight here
News-ID: 4373935 • Views: …
More Releases from ABNewswire
Pool installation in Van Alstyne, TX provided by DSH Custom Home & Pool Builders …
DSH Custom Home & Pool Builders is a cornerstone for pool installation in Van Alstyne, TX. As a partner of Nationwide Contracting, the firm utilizes a broad resource network to ensure all projects meet the highest safety and efficiency standards. Whether for excavation or long-term preservation, they provide residents with the professional support needed for successful property enhancement.
Pool installation in Van Alstyne, TX
The availability of professional pool installation [https://dshbuild.com/#:~:text=Home%20Build%0ACustom-,Pool%20Installation,-Above%2DGround%20Pool] in…
How Ontario Therapy in Newmarket is Helping Clients Overcome Trauma with Proven …
Ontario Therapy in Newmarket helps clients overcome trauma with proven techniques, offering personalized support for lasting healing and recovery.
Newmarket, ON - Ontario Therapy, a leading provider of trauma therapy in Newmarket, is committed to helping individuals heal from the effects of trauma using proven therapeutic techniques. The clinic's personalized approach focuses on providing tailored care to meet each client's specific needs, helping them achieve emotional well-being and take steps toward…
Attorney Big Al California Offers Top Legal Advice for Car Accident Claims in Ea …
Attorney Big Al in California offers expert legal advice for car accident claims in East Hemet, helping victims get the compensation they deserve.
Sherman Oaks, CA - Attorney Big Al California, a trusted name in personal injury law, is proud to offer expert legal services to residents of East Hemet and the surrounding areas. Specializing in car accident claims, the firm provides compassionate, results-driven legal representation to individuals seeking justice after…
Magical Moments ABA's In-Home Therapy Approach: Personalized Care for Every Chil …
Magical Moments ABA offers personalized in-home therapy tailored to each child's needs, providing effective care for children with autism in a comfortable setting.
Marietta, GA - Magical Moments ABA is excited to introduce its unique in-home therapy approach, designed to provide personalized care for children with autism and developmental delays. This therapy model focuses on developing individualized treatment plans that address each child's unique needs, ensuring they receive the best support…
More Releases for Myelofibrosis
Primary Myelofibrosis (PMF) Market Insights and Future Outlook
Introduction
Primary myelofibrosis (PMF) is a rare, chronic myeloproliferative neoplasm characterized by progressive bone marrow fibrosis, splenomegaly, anemia, and systemic symptoms such as fatigue, night sweats, and weight loss. Unlike secondary myelofibrosis, which arises from other blood cancers, PMF develops as a distinct disease entity, typically driven by mutations in JAK2, CALR, or MPL genes.
PMF has long been associated with poor prognosis and limited therapeutic options. Historically, treatment focused on symptom…
Myelofibrosis Pipeline Therapeutics Assessment Report 2024 (Updated)
DelveInsight's, "Myelofibrosis Pipeline Insight 2024" report provides comprehensive insights about 35+ companies and 40+ pipeline drugs in Myelofibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore our latest breakthroughs in Myelofibrosis Research. Learn more about our innovative…
Secondary Myelofibrosis Therapeutics Market - Revolutionizing Treatment for Seco …
Newark, New Castle, USA: The "Secondary Myelofibrosis Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Secondary Myelofibrosis Therapeutics Market: https://www.growthplusreports.com/report/secondary-myelofibrosis-therapeutics-market/8885
This latest report researches the industry structure,…
Myelofibrosis Market - Transforming Challenges into Triumphs: Myelofibrosis Mark …
Newark, New Castle, USA: The "Myelofibrosis Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Myelofibrosis Market: https://www.growthplusreports.com/report/myelofibrosis-market/8802
This latest report researches the industry structure, sales, revenue, price and…
Secondary Myelofibrosis Therapeutics Market - Unleashing Resilience, Defying Mye …
Newark, New Castle, USA - new report, titled Secondary Myelofibrosis Therapeutics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Secondary Myelofibrosis Therapeutics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Secondary Myelofibrosis Therapeutics market. The report offers an overview of…
Chronic Idiopathic Myelofibrosis Market 2022 | Detailed Report
The Chronic Idiopathic Myelofibrosis report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry.
The Chronic Idiopathic Myelofibrosis report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,…
